<?xml version="1.0" encoding="UTF-8"?>
<p>Every medical decision regarding the treatment of COVID-19 patients should be taken after a thorough analysis of the risk/benefit ratio and all adverse events should be reported in order to fill the gaps in the RDV toxicological profile.</p>
